$0.00
| Model : | Solids |
| Company name : | Temad Co |
| Packaging : | |
| Minimum order : | 1 |
| Standard : | ISO 45001:2018, GMP PRM-98-11 |
| Production power : |
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
This product is SinaDoxosome containing liposomal hydrochloride doxorubicin. Its formulation is in a way that inserts doxorubicin into the nanoliposome carriers and increases permeability and retention of the drug in the tumor tissue. This lipid carrier decreases the side effects of doxorubicin due to the small amount of leakage. In this way cardiac toxicity of the drug that is the most dangerous side effect is significantly reduced. SinaDoxosome is used in the treatment of various cancers and because of the high efficiency of its liposomal nature, it has significant effect on metastatic cancers including metastatic breast, ovarian cancers as well as multiple myeloma and AIDS-related Kaposi’s sarcoma.
Reviews
There are no reviews yet.